You are here

Strattera

Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents

Stat

Wed, 08/16/17 - 11:11 am

Lilly's Strattera faces first wave of generic competition

BioPharma Dive

Fri, 06/2/17 - 11:31 am

Teva Pharmaceutical

Top 10 U.S. patent losses of 2017

Fierce Pharma

Thu, 02/23/17 - 09:29 am

Sandostatin LAR

Bristol-Myers Squibb

Gilead Sciences

The Top 5 Drug Patents Expiring in 2017

Investopedia

Mon, 01/16/17 - 11:48 am

Bristol-Myers Squibb

Sandostatin LAR

Lilly Offers ‘Misleading’ Facts in our Patent Dispute, Says Canada

WSJ Online

Tue, 07/15/14 - 11:49 am

New attention disorder could equal a big new ADHD drug market

Fierce Pharma

Mon, 04/14/14 - 06:36 pm

Sluggish Cognitive Tempo

attention deficit disorder

A Closer Look at the Controversial Market Growth of ADHD Treatments

Motley Fool

Wed, 08/28/13 - 04:49 pm

Eli Lilly says court backs Strattera patent

Yahoo/AP

Sat, 07/30/11 - 09:57 am

Lilly wins longer halt of generic Strattera sales

Reuters

Fri, 08/27/10 - 11:32 am

Teva Pharmaceuticals

Lilly's Glimmers of Light Unlikely to Bring Future Growth

Seeking Alpha

Sun, 08/22/10 - 12:26 pm

Lilly Asks Court To Temporarily Block Generic Strattera

NASDAQ.com

Mon, 08/16/10 - 05:55 pm

U.S. District Court Rules Against Lilly Regarding Strattera Patent

Yahoo

Fri, 08/13/10 - 07:29 am